UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 1, 2026
Sale
Calculated transaction value
$404.08K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 31, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$510.38
Aug 31, 2026
Close before public filing
$510.38
Aug 31, 2026
Return since public filing
-2.6%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 794 shares @ $508.92
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000132
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$6.14M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Aug 31, 2026 | $348.15K |
| United Therapeutics Corp UTHR | Sale | Aug 31, 2026 | $391.91K |
| United Therapeutics Corp UTHR | Sale | Aug 31, 2026 | $412.97K |
| United Therapeutics Corp UTHR | Sale | Aug 31, 2026 | $2.15M |
| United Therapeutics Corp UTHR | Sale | Aug 31, 2026 | $818.8K |
| United Therapeutics Corp UTHR Current | Sale | Aug 31, 2026 | $404.08K |
| United Therapeutics Corp UTHR | Exercise | Aug 31, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 31, 2026 | $304.2K |
| United Therapeutics Corp UTHR | Sale | Aug 31, 2026 | $20.6K |
| United Therapeutics Corp UTHR | Exercise | Aug 31, 2026 | $0 |